Nuvation Bio Inc.·4

Mar 4, 6:29 PM ET

Hanley David C. 4

4 · Nuvation Bio Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-28+500,000500,000 total
    Exercise: $1.97Exp: 2035-02-27Class A Common Stock (500,000 underlying)
Holdings
  • Class A Common Stock

    18,000
Footnotes (2)
  • [F1]Includes 3,000 shares acquired on May 17, 2024 and 3,000 shares acquired on November 19, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
  • [F2]Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Documents

1 file
  • 4
    form4-03042025_110344.xmlPrimary